Biocytogen Boston Competitors and Similar CompaniesClear all

Biocytogen Boston's competitors and similar companies include Editas Medicine, Caribou Biosciences and Aglaris.

	Biocytogen Boston Biocytogen Boston is a company that provides antibody drug development solutions.	Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.	Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.	Aglaris Aglaris is a company automating and controlling the cell culture processes.
Founding Date	Founding Date 2008	Founding Date 2013	Founding Date 2012	Founding Date 2012
Type	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Technology bioengineering biotech medtech
Locations	Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US	Locations Cambridge, US HQ Boulder, US Cambridge, US	Locations Berkeley, US HQ	Locations Stevenage, GB HQ Tres Cantos, ES
Employees	Employees 1833% increase	Employees 20816% increase	Employees 1477% decrease	Employees 13
Valuation ($)	Valuation ($) N/A	Valuation ($) 256.5 m	Valuation ($) 174.4 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $40.5m (FY, 2025)	Revenue (est.) $11.2m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($160.1m) (FY, 2025)	Net income ($148.1m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 284.3m	Total funding raised $ 210m	Total funding raised $ 159.5m	Total funding raised N/A